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If you believe the fluid mosaic model
of membrane structure, all the
important jobs of the cell membrane,
such as nutrient uptake, ion transport
and transduction of hormonal signals,
are attributable to membrane
proteins rather than to the lipid
bilayer in which they sit. But if all
the membrane lipids do is to form a
permeability barrier, you might
expect them to have quite uniform
structures. In fact, they are highly
diverse, suggesting they have
additional, more subtle roles in
membrane function.
One of the most important and
best understood roles of membrane
lipids and/or their products is to
function as intracellular second
messengers, which convey the
information encoded in extracellular
messengers, such as hormones,
neurotransmitters and growth factors,
to produce an appropriate cellular
response. More recently, lipids have
been shown to regulate essential
functions of membranes themselves,
providing crucial, yet poorly
understood, signals which control the
flow of membrane traffic between the
major organelles of eukaryotic cells.
Specialised signalling roles
The inositol-containing phospholipids
are minor membrane constituents
that have diverse chemical structures.
They provide cells with an
astonishing variety of signals whose
functions we are only just beginning
to understand in detail.
Phosphatidylinositol 4,5-bisphosphate
(PI(4,5)P2) is one of the lynchpins of
this network of putative signalling
molecules. It is the major substrate
for two groups of stimulus-
dependent enzymes. Enzymes of the
phospholipase C family (PLCs)
cleave PI(4,5)P2 to generate two
independent second messengers:
diacylglycerol (DAG), which
activates several species of protein
kinase C, and inositol
1,4,5-trisphosphate (I(1,4,5)P3), which
releases Ca2+ from intracellular stores.
The second group of enzymes, type I
PI 3-kinases, phosphorylate PI(4,5)P2
to generate phosphatidylinositol
3,4,5-trisphosphate (PI(3,4,5)P3)
whose functions will be discussed
later (see Figure 1). PI 3-kinases and
PLCs are found in all eukaryotic
cells and their activities are regulated
by a wide variety of hormones,
neurotransmitters and growth factors.
In addition to its role as a
precursor of signals, PI(4,5)P2 seems
to function as a distinct signal in its
own right. For example, it can
regulate actin polymerisation via its
interaction with proteins such as
profilin, gelsolin and vinculin; it is a
necessary co-factor for another
signal-generating enzyme,
phospholipase D (discussed later);
and its synthesis on the cytosolic
leaflets of secretory vesicles seems to
be required to confer secretory
competence on these structures.
How can a single lipid have so
many different roles? The answers
are only just beginning to emerge
but two important properties of
PI(4,5)P2, and of the enzymes that
regulate its level in cells, illustrate
principles which are likely to be
common themes of lipid signalling.
Location
One mechanism by which the
functions of inositol phospholipids
could remain distinct would be the
spatial segregation of pools of
different membrane lipids. The
precursor phospholipid
phosphatidylinositol (PI), can be
targeted to distinct membrane
compartments by a PI transfer
protein. Because inositol
phospholipids are likely to remain in
the membrane in which they are
synthesized, it should be possible for
lipid kinases — which could be
either cytosolic or specific to the
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Figure 1
The many different roles of phosphatidylinositol
4,5-bisphosphate (PI(4,5)P2),which is a
precursor of the signals PI(3,4,5)P3, DAG
and I(1,4,5)P3, as well as functioning as a
signal in its own right. The structure of
PI(4,5)P2 shows the typical inositol
headgroup, which is linked by a
phosphodiester phosphate group at the 1
position to the third carbon of the glycerol
backbone. Stearic acid at the 1 position and
arachidonic acid at the 2 position of glycerol
provide the lipid components which anchor
these inositol phospholipids within the
cytosolic leaflets of cellular membranes.
Phophate groups (P) are shown in green.
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relevant membrane compartment
— to synthesize spatially segregated
pools of PI(4,5)P2 for particular
purposes.
Several isoforms of PI and PIP
kinases have been isolated and
cloned, providing invaluable tools
with which to test this attractive
hypothesis. One thing we can say is
that in many cells a majority of the
PI(4,5)P2 is located in the plasma
membrane, where it is immediately
available for hydrolysis by receptor-
stimulated PLCs. It also seems likely
that PI 3-kinases will access the
same, or at least an overlapping, pool
of this lipid. Other functions of
PI(4,5)P2, such as those illustrated in
Figure 1, must therefore involve
relatively small pools of this lipid,
probably located in other
intracellular membranes.
Specific protein binding
The inositol phosphate headgroups
of the inositol phospholipids are
ideally suited to forming high-
affinity, structure-dependent
interactions with target proteins. For
example I(1,4,5)P3, the soluble
product of PLC activity, binds to its
specific receptor in the endoplasmic
reticulum with an affinity at least
one-thousand-fold greater than
those of closely related molecules
such as I(1,3,4)P3.
An important breakthrough in
understanding inositol-lipid-
dependent signalling mechanisms has
been the discovery of small protein
domains, known as pleckstrin
homology (PH) domains, which have
the characteristics required of
receptors for PI(4,5)P2, PI(3,4,5)P3
and PI(3,4)P2. These lipids bind to
distinct subsets of the PH domains,
which are present in a large number
of functionally distinct proteins, many
of which seem to have important roles
in signalling. This binding interaction
brings the receptor protein to the
membrane in which its lipid ligand is
located and may in addition directly
regulate the protein’s activity.
One of the best understood
examples of this type of mechanism
concerns the activation of protein
kinase B (PKB), a central component
of insulin- and growth-factor-
signalling pathways. PKB and an
upstream regulatory kinase,
phosphoinositide-dependent protein
kinase 1 (PDK1), both have PH
domains that bind PI(3,4,5)P3 with
high affinity and specificity. This has
at least two effects: it brings PKB and
PDK1 together at the plasma
membrane when PI(3,4,5)P3 levels
rise in response to, say, insulin, and it
induces a conformational change in
the structure of PKB that exposes a
threonine residue which is then
phosphorylated by PDK1 (Figure 2).
This lipid-dependent co-localisation,
allowing phosphorylation and
activation, is a common mechanism
for diverse PI(3,4,5)P3-mediated
signalling pathways.
Another example of a specific
phosphoinositide receptor is the
EEA1 protein, which contains a
cysteine-rich domain called a FYVE
finger. This domain binds to PI3P, a
lipid signal produced by distinct
families of PI 3-kinases that only use
PI as a substrate. Through this
interaction, specific membrane
sorting events such as vesicle
docking and/or fusion, may be
controlled by mechanisms that cause
the local synthesis of PI3P. The use
of a lipid — locked to the surface of
the vesicle in which it was made —
as a signal in membrane trafficking
events is an elegant solution to the
problem of fidelity in membrane
dynamics.
The phospholipase paradox
As mentioned already, the
hydrolysis of PI(4,5)P2 by PLCs
generates a lipid signal, DAG
(Figure 1), which activates several
species of protein kinase C. DAG is
then rapidly metabolised by DAG
kinases to phosphatidate (PA). More
recent studies have identified a
second type of phospholipase,
phospholipase D (PLD), which is
activated by a wide variety of cell
stimuli and catalyses hydrolysis of
the membrane phospholipid
phosphatidylcholine directly to PA;
then PA phosphohydrolases convert
this PA to DAG.
Despite the fact that they
apparently generate the same overall
products, several lines of evidence
suggest that cellular responses which
result from activation of PLD are
functionally distinct from those that
result from activation of PLCs.
Moreover, both DAG and PA are
critical intermediates in lipid
biosynthetic pathways, so there must
be a mechanism for segregating the
housekeeping roles of these lipids
from their evident signalling
functions.
The solutions to these apparent
paradoxes are likely to involve the
general principles of location and
structural specificity discussed
already. For example, PLCs generate
mainly DAG/PA with stearoyl
arachidonoyl fatty acid tails,
reflecting the fatty acid composition
of the PI(4,5)P2 from which they
were derived. These lipids are then
recycled back to resynthesize the
signalling pool of PI, apparently
without impinging upon de novo
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Figure 2
PI(3,4,5)P3-mediated localization and
activation of PKB. Protein kinases PDK1 and
PKB are co-localised through binding of their
respective PH domains to PI(3,4,5)P3 (which
is formed when PI 3-kinase is activated). This
binding induces a conformational change in
PKB, which exposes a threonine residue that
is phosphorylated by PDK1, which in turn
activates PKB.
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phospholipid biosynthetic pathways.
How this is achieved is one of the
main unanswered questions in lipid
signalling.
By contrast, PLDs generate
mainly PA species with saturated or
mono-unsaturated fatty acid tails and
there is emerging evidence that
these products exert specific cellular
responses, including triggering the
formation of actin stress fibres,
stimulation of exocytosis and
regulation of vesicle formation.
Whether they achieve these effects
by binding to protein targets specific
for these PA species, or through the
biophysical effects resulting from
hydrolysis of phosphatidylcholine —
which is a major structural component
of membranes — is not yet clear.
The recent cloning of genes
encoding eukaryotic PLDs has been
an important breakthrough that
promises to help solve some of the
unanswered questions in this field.
Two major isoforms, PLD1 and
PLD2, have been identified to date
in mammalian cells. PLD1 requires
PI(4,5)P2 as a co-factor and is
confined to the perinuclear region of
cells, whereas PLD2 is found mainly
in the plasma membrane. This
differential localization and their
different regulatory properties
suggest PLD1 and PLD2 have
distinct cellular roles.
Sphingomyelin and cell death
Sphingomyelin is a membrane
phospholipid that is derived from
sphingosine (as opposed to glycerol,
like the inositol phospholipids).
There is a growing body of evidence
that sphingomyelin can serve as a
source of lipid second messengers,
but this idea is still controversial and
currently raises far more questions
than it answers. The evidence
includes the fact that many stimuli in
a range of cell types cause the
apparent hydrolysis of sphingomyelin,
leading to detectable increases in the
level of ceramide and sometimes also
of a secondary product of ceramide
metabolism, sphingosine
1-phosphate. It is not known which
sphingomyelinase(s) is/are
responsible for the accumulation of
ceramide, nor even whether the
stimulated reaction involves a
sphingomyelinase or some other
route of ceramide synthesis and/or
metabolism.
More convincing than the above
are the numerous observations that
the addition of ceramide or
sphingosine 1-phosphate to cells
induces well-characterized cellular
responses consistent with these
molecules having signalling roles.
Even here, unresolved questions
abound: for example, sphingosine
1-phosphate has been claimed to act
intracellularly by releasing Ca2+ from
intracellular stores in a similar
response to that effected by
I(1,4,5)P3. More recently, however,
convincing claims have been made
for an extracellular role of
sphingosine 1-phosphate acting via a
cell-surface receptor.
A more consistent picture is
beginning to emerge, however,
regarding the effects of ceramide on
cell behaviour. Early studies with
ceramide analogues suggested they
were toxic to cells but it emerged
subsequently that ceramide-induced
toxicity bore all the hallmarks of
programmed cell death, or apoptosis.
Moreover, these effects were
structurally specific, because close
structural analogues with similar
overall lipid character did not
reproduce responses to ceramide
itself. Such structural specificity
implies the existence of protein
receptors that bind and respond to
ceramide. Although several
candidates have been proposed,
however, including protein kinases
and phosphatases, there is still no
convincing evidence that any of
these proteins is a physiologically
significant ceramide receptor.
If sphingomyelin and its
metabolites are going to emerge as
ubiquitous signalling molecules,
some fundamental questions need to
be resolved. Not least of these is the
identities of sphingomyelinases
which account for the synthesis of
putative second messengers, such as
ceramide, in response to appropriate
stimuli. Also, sphingomyelin, like
phosphatidylcholine, is likely to have
both structural and signalling roles.
We need to know how these roles are
segregated and whether the pools of
signalling sphingomyelin are
intracellular or on the outer leaflet of
the plasma membrane, where most
of the sphingolipids are found. Nor
do we yet have convincing
candidates for ceramide receptors or
know which signalling pathways that
feed into the central apoptotic
mechanisms they trigger.
These are not criticisms. In fact,
they are remarkably similar questions
to those that were being asked by
researchers in the early 1980s who
were convinced of the importance of
inositol lipids in signalling; and look
where addressing those questions has
led us.
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